镰状细胞病中的二尖瓣置换术。
Mitral valve replacement in sickle cell disease.
作者信息
Sgambati M T, Kon N D, Cruz J M
机构信息
Department of Internal Medicine/Hematology and Oncology, Bowman Gray School of Medicine, Winston-Salem, North Carolina, USA.
出版信息
Clin Cardiol. 1998 Aug;21(8):602-3. doi: 10.1002/clc.4960210814.
Abstract
Cardiac dysfunction, including mitral valve regurgitation and congestive heart failure, can occur in patients with sickle cell disease. However, major surgery poses a greater risk in this population. This paper reports on the management of a patient with sickle cell disease who underwent successful replacement of the mitral valve.
摘要
心脏功能障碍，包括二尖瓣反流和充血性心力衰竭，可发生于镰状细胞病患者。然而，重大手术在这一人群中带来的风险更大。本文报告了一例镰状细胞病患者成功进行二尖瓣置换术的治疗情况。
相似文献
1
Mitral valve replacement in sickle cell disease.镰状细胞病中的二尖瓣置换术。
Clin Cardiol. 1998 Aug;21(8):602-3. doi: 10.1002/clc.4960210814.
2
Mitral valve replacement and tricuspid valve repair in a patient with sickle cell disease.镰状细胞病患者的二尖瓣置换术和三尖瓣修复术。
Thorac Cardiovasc Surg. 2008 Feb;56(1):56-7. doi: 10.1055/s-2007-965765.
3
4
Risk Factors for Mitral Valve Surgery: Atrial Fibrillation and Pulmonary Hypertension.
Semin Cardiothorac Vasc Anesth. 2019 Mar;23(1):57-69. doi: 10.1177/1089253218821694. Epub 2019 Jan 4.
5
How should I treat a severely symptomatic, high-risk female patient with degenerated mitral (Carpentier-Edwards porcine) and aortic (Sorin Mitroflow) bioprostheses?对于一名患有退化性二尖瓣（Carpentier-Edwards猪生物瓣）和主动脉瓣（Sorin Mitroflow）生物瓣且症状严重、风险高的女性患者，我该如何治疗？
EuroIntervention. 2015 Feb;10(10):1250-2. doi: 10.4244/EIJY14M09_03.
6
Mitral valve replacement in Sickle C disease using intraoperative exchange transfusion.
J Card Surg. 1998 Jan;13(1):48-50. doi: 10.1111/j.1540-8191.1998.tb01054.x.
7
Transapical Mitral Valve Replacement for Mixed Native Mitral Stenosis and Regurgitation.经心尖二尖瓣置换术治疗混合性原发性二尖瓣狭窄和反流
Ann Thorac Surg. 2016 Aug;102(2):e97-9. doi: 10.1016/j.athoracsur.2015.12.042.
8
The Alfieri stitch: the advantages for mitral valve repair in difficult circumstances.阿尔菲里缝合术：困难情况下二尖瓣修复的优势。
J Card Surg. 2011 Sep;26(5):475-7. doi: 10.1111/j.1540-8191.2011.01295.x. Epub 2011 Aug 31.
9
Fate of mild aortic valve disease after mitral valve intervention.二尖瓣干预后轻度主动脉瓣疾病的转归
J Thorac Cardiovasc Surg. 2001 Sep;122(3):583-6. doi: 10.1067/mtc.2001.115916.
10
Development of a Severe Mitral Valve Stenosis Secondary to the Treatment of Mitral Regurgitation with a Single MitraClip.单枚MitraClip治疗二尖瓣反流后继发严重二尖瓣狭窄的发生情况
J Card Surg. 2016 Mar;31(3):153-5. doi: 10.1111/jocs.12692. Epub 2016 Jan 24.
本文引用的文献
1
Case 2--1996. Anesthetic management of a patient with hemoglobin SS disease and mitral insufficiency for mitral valve repair.
J Cardiothorac Vasc Anesth. 1996 Apr;10(3):419-24. doi: 10.1016/s1053-0770(96)80108-x.
2
Mitral valve reconstruction in sickle cell disease.镰状细胞病中的二尖瓣重建术。
Ann Thorac Surg. 1996 Jun;61(6):1841-3. doi: 10.1016/0003-4975(96)80209-8.
3
Sickle cell disease.镰状细胞病
Pediatr Clin North Am. 1996 Jun;43(3):639-64. doi: 10.1016/s0031-3955(05)70426-0.
4
A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.镰状细胞病围手术期管理中保守与积极输血方案的比较。镰状细胞病术前输血研究组。
N Engl J Med. 1995 Jul 27;333(4):206-13. doi: 10.1056/NEJM199507273330402.
5
Aortic and mitral valve replacement after sickle cell crisis.镰状细胞危象后的主动脉瓣和二尖瓣置换术。
Anesth Analg. 1982 Sep;61(9):802.
6
Open-heart surgery in patients with hematologic disorders.
Am Heart J. 1983 May;105(5):835-42. doi: 10.1016/0002-8703(83)90249-1.
7
Management of patients with sickle cell disease.镰状细胞病患者的管理
Med Clin North Am. 1992 May;76(3):669-82. doi: 10.1016/s0025-7125(16)30346-7.
Zotero 插件